Menier's Disease - Bone Density Study

Launched by HAEMEK MEDICAL CENTER, ISRAEL · Apr 3, 2022

Keywords

ClinConnect Summary

This clinical trial, called the Menier's Disease - Bone Density Study, is looking into how Meniere's disease, a condition that affects the inner ear and causes symptoms like dizziness and hearing loss, relates to bone health and vitamin D levels. Researchers want to understand if people with Meniere's disease have lower bone density, which could lead to conditions like osteoporosis (weak bones). Over two years, participants with confirmed Meniere's disease will have their bone density, vitamin D levels, blood pressure, and hearing tested regularly. The results will be compared to those from healthy individuals to see if there are significant differences.

To be eligible for this study, participants must be diagnosed with definite Meniere's disease. However, individuals with certain medical conditions, such as thyroid problems, diabetes, or those taking specific long-term medications, will not be able to participate. For those who join the study, they can expect to have several health tests done over the two years, including measurements of their bone density and vitamin D levels. This research aims to better understand the connection between Meniere's disease and bone health, which could help improve care for patients in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Definite Meniere's disease
• Exclusion Criteria:
• • hyperthyroidism
• • hyperparathyroidism
• • acromegaly
• • hypogonadism
• • diabetes melitus
• • chronic renal failure
• • alcoholism
• • cushing syndrome
• • rheumatoid arthritis
• • systemic lupus erythematosus
• • ankylosing spondylitis
• • inflammatory bowel disease
• • obstructive lung disease
• • sarcoidosis
• • amyloidosis
• • celiac disease.
• • chronic treatment with bisphosphonates
• • chronic treatment with glucocorticoids
• • chronic treatment with androgen deprivation therapy
• • chronic treatment with gonadotropin releasing hormone agonist chronic treatment with aromatase inhibitor chronic treatment with loop diuretics chronic treatment with proton pump inhibitors chronic treatment with anti-seizure drugs chronic treatment with warfarin chronic treatment with SSRI chronic treatment with alpha or beta-blockers